Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity

被引:148
作者
Levin, BE
Dunn-Meynell, AA
机构
[1] Vet Affairs Med Ctr, Neurol Serv 127C, E Orange, NJ 07018 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA
关键词
neuropeptide Y; proopiomelanocortin; dynorphin; opioids; set point; arcuate nucleus;
D O I
10.1152/ajpregu.2002.282.1.R46
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Sprague-Dawley rats selectively bred for diet-induced obesity (DIO) or diet resistance (DR) were characterized on diets of differing energy content and palatability. Over 10 wk, DR rats on a high-energy (HE) diet (31% fat) gained weight similarly to DR rats fed chow (4.5% fat), but they became obese on a palatable liquid diet (Ensure). DIO rats gained 22% more weight on an HE diet and 50% more on Ensure than chow-fed DIO rats. DIO body weight gains plateaued when switched from HE diet to chow. But, Ensure-fed DIO rats switched to chow spontaneously reduced their intake and weight to that of rats switched from HE diet to chow. They also reduced their hypothalamic proopiomelanocortin and dynorphin but not neuropeptide Y mRNA expression by 17-40%. When reexposed to Ensure after 7 wk, they again overate and matched their body weights to rats maintained on Ensure throughout. All Ensure-fed rats had a selective reduction in dynorphin mRNA in the ventromedial hypothalamic nucleus. Thus genetic background, diet composition, and palatability interact to produce disparate levels of defended body weight and central neuropeptide expression.
引用
收藏
页码:R46 / R54
页数:9
相关论文
共 30 条
[1]   Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: A comparison with fluoxetine [J].
Caccia, S ;
Confalonieri, S ;
Bergami, A ;
Fracasso, C ;
Anelli, M ;
Garattini, S .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (04) :851-856
[2]   Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products [J].
Dunbar, JC ;
Lu, HQ .
BRAIN RESEARCH BULLETIN, 1999, 50 (03) :215-221
[3]   Intracarotid glucose selectively increases Fos-like immunoreactivity in paraventricular, ventromedial and dorsomedial nuclei neurons [J].
DunnMeynell, AA ;
Govek, E ;
Levin, BE .
BRAIN RESEARCH, 1997, 748 (1-2) :100-106
[4]   AN OPIOID ANTAGONIST, NALTREXONE, REDUCES PREFERENCE FOR SUCROSE IN HUMANS [J].
FANTINO, M ;
HOSOTTE, J ;
APFELBAUM, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (01) :R91-R96
[5]   EFFECTS OF AN OVERFEEDING REGIMEN - THE AFFECTIVE COMPONENT OF THE SWEET SENSATION [J].
FANTINO, M ;
BAIGTS, F ;
CABANAC, M ;
APFELBAUM, M .
APPETITE, 1983, 4 (03) :155-164
[6]   Differential effects of neuropeptide Y and the μ-agonist DAMGO on 'palatability' vs. 'energy' [J].
Giraudo, SQ ;
Grace, MK ;
Billington, CJ ;
Levine, AS .
BRAIN RESEARCH, 1999, 834 (1-2) :160-163
[7]   Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy [J].
Glass, MJ ;
Billington, CJ ;
Levine, AS .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 279 (01) :R86-R92
[8]  
Hagan MM, 1999, J NEUROSCI, V19, P2362
[9]   SOMATOSTATIN-IMMUNOREACTIVE NEURONS IN THE HYPOTHALAMIC VENTROMEDIAL NUCLEUS POSSESS ESTROGEN-RECEPTORS IN THE MALE AND FEMALE RAT [J].
HERBISON, AE .
JOURNAL OF NEUROENDOCRINOLOGY, 1994, 6 (03) :323-328
[10]  
HIGUCHI H, 1988, J BIOL CHEM, V263, P6288